Acurx Pharmaceuticals at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Acurx Pharmaceuticals brings 2 presentations to IDWeek 2026 in Washington, and exhibits at Booth 620. Its program centres on a new antibiotic for Clostridioides difficile infection. The drug aims both to treat the infection and to cut the risk of it returning.
| Organization | IDWeek 2026 Attendance |
|---|---|
Acurx Pharmaceuticals Staten Island, NY | |
Clinical-stage company developing a new class of antibiotics against bacteria that health agencies rank as priority pathogens. | Booth Exhibiting at Booth 620 Thu, Oct 2210am–2pmFri, Oct 2310am–2pmSat, Oct 2410am–2pm Industry Thu Oct 22 10:30am–10:50am Novel Antibiotic for Both the Treatment and the Reduction of Recurrence of C. difficile Infection Antimicrobials, resistance and stewardship Industry Sat Oct 24 11:00am–11:20am Novel Antibiotic for Both the Treatment and the Reduction of Recurrence of C. difficile Infection Antimicrobials, resistance and stewardship |
Instantly find 20 buyers from Acurx Pharmaceuticals
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction